ASSAD MUJTABA: Open Payments
NPI 1699230359 · CLIFTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 13 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $388 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $102 |
| Novo Nordisk Inc | 3 | $59 |
| Amgen Inc. | 2 | $33 |
| ABBVIE INC. | 2 | $32 |
| Intra-Sana Laboratories | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $16 |
| Madrigal Pharmaceuticals | 1 | $16 |
Products named: DAXXIFY, Ozempic, OTEZLA, QULIPTA, RELTONE 200 MG, AUSTEDO XR, XYOSTED, REZDIFFRA.
Industry payments across NJ — which companies pay providers there.
